Al Razi Medical issues prospectus for 20% IPO on Nomu

07/05/2023 Argaam

Logo of Al Razi Medical Co.


Al Razi Medical Co. issued today, May 7, its prospectus to float 304,000 shares, or 20% of its SAR 15.2 million capital, on Nomu-Parallel Market.

 

The share sale will run from June 4-6 for qualified investors. 

 

The offering will be confined to qualified investors stipulated in the glossary of defined terms used in the regulations and rules of the Capital Market Authority (CMA).

 

Al Razi Medical is a closed Saudi joint stock company, established as a sole proprietorship in 2006. It is headquartered in Al Badayea city.

 

The company’s activity, as per its commercial register, is represented in the pharmacy activity. Its current activity is in storage, sale and marketing of pharmaceuticals, medical preparations and cosmetics.

 

CMA approved, on April 3, the application submitted by the company to offer its shares on Nomu.

 

Company Profile

Company

 Al Razi Medical Co.

Market

Nomu-Parallel Market

Core activities

Pharmacy activities

Capital

SAR 15.2 mln

 

IPO Summary

Issue Percentage

20%

Offered shares

304,000 

Minimum limit

10 shares

Maximum limit

74,000 shares

Offer period

June 4-6, 2023

Final Allocation

June 11, 2023

Refund (if any)

June 12, 2023

 

Company Shareholders

Shareholders

Before IPO

Post-IPO

Number of Shares

(‘000)

Ownership (%)

Number of Shares

(‘000)

Ownership (%)

Yousuf Abdullah Yousuf Al Arini

1141.9

75.1%

994.9

65.5%

Mohammed Abdullah Suleiman Al Saghir

29.2

1.9%

6.9

0.5%

Fawziya Suleiman Abdullah Al Saghir

24.0

1.6%

13.9

0.9%

Mohammed Abdullah Suleiman Ebeid

22.1

1.5%

12.8

0.8%

Others

302.8

19.9%

187.5

12.3%

QFIs

--

--

304.0

20.0%

Total

1520.0

100%

1520.0

100%

 

Additional Information

Financial Advisor  

Team One Co.

Lead Manager

Derayah Financial

 

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Most Read